Wolverine Trading, LLC 23and Me Holding Co. Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.61 $1,104 - $1,872	3,069 Added 23.73%	16,003 $6,000
Q1 2024 May 15, 2024	SELL	$0.4 - $0.91 $4,802 - $10,926	-12,007 Reduced 48.14%	12,934 $6,000
Q4 2023 Feb 14, 2024	SELL	$0.71 - $0.97 $2,804 - $3,831	-3,950 Reduced 13.67%	24,941 $22,000
Q3 2023 Nov 15, 2023	BUY	$0.96 - $2.01 $5,050 - $10,574	5,261 Added 22.26%	28,891 $28,000
Q2 2023 Aug 23, 2023	BUY	$1.59 - $2.29 $15,291 - $22,022	9,617 Added 68.63%	23,630 $41,000
Q1 2023 May 15, 2023	SELL	$2.05 - $2.87 $12,232 - $17,125	-5,967 Reduced 29.86%	14,013 $32,000
Q4 2022 Feb 14, 2023	BUY	$2.06 - $3.47 $41,158 - $69,330	19,980 New	19,980 $43,000
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $62,110 - $134,824	18,936 Added 96.19%	38,622 $151,000
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $17,193 - $34,781	2,625 Added 15.39%	19,686 $136,000
Q3 2021 Nov 12, 2021	SELL	$7.29 - $11.0 $418,066 - $630,828	-57,348 Reduced 77.07%	17,061 $146,000
Q2 2021 Aug 06, 2021	BUY	$9.87 - $13.32 $734,416 - $991,127	74,409 New	74,409 $857,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.